Deborah L. Cummins, MD
Assistant Professor of Dermatology
Director of Mohs and Dermatologic Surgery
at Boston Medical Center
Boston University School of Medicine, Dept of Dermatology
609 Albany Street, Boston, MA 02118
Tel: 617-638-5500 Fax 617-638-5515
Deborah L. Cummins, MD is the Director of Mohs and Dermatologic Surgery at Boston Medical Center. She graduated from Brown University and received her M.D. degree from Johns Hopkins School of Medicine with academic honors including membership in Phi Beta Kappa and Alpha Omega Alpha Honor Societies. She completed her internship in internal medicine at Johns Hopkins-Bayview Medical Center and residency in dermatology at Harvard Medical School-Massachusetts General Hospital. She also received fellowship training in Mohs Dermatologic Surgery and Cutaneous Oncology at Tufts Medical Center. She is a member of the American College of Mohs Surgery and the American Academy of Dermatology. Her clinical and research interests include surgical dermatology and skin cancer. She is the author of multiple publications related to surgical reconstruction, basal cell carcinoma, tanning, and melanoma.
Mohs Micrographic Surgery
1 Lenzy, Y, Cummins DL, Finn DT, “Bipolar Forceps – A Hemostatic Tool for Patients with Electrocoagulation-Induced Dental Pain” Journal of the American Academy of Dermatology. 2011 Aug 65(2): 441-2
2 Cummins DL, Yu Y, Finn DT, “Island Pedicle Reconstruction of Partial Nipple and Areola Defect” Dermatologic Surgery. 2010 Sep 36(9): 1459-62
3 Martin JM, Ghaferi JM, Cummins, DL, Mamelak AJ, Parikh M, Richardson HV, Stein D, Liegeois, “Fashion Articles and Advertisements in the early 20th Century: Changes in Skin Tanning Attitudes Correlate to the Years 1927-1928” American Journal of Public Health, 2009 Dec; 99(12): 2140-6
4 Cummins DL, Esche C, Barrett TL, Balch CM, Mofid M, “Lymph Node Biopsy Results for Desmoplastic Melanoma” Cutis, 2007 May, 79(5): 390-4.
5 Cummins DL, Mimouni D, Tsu J, Owens N, Anhalt GJ, Meyerle J “Lichenoid Paraneoplastic Pemphigus in the Absence of Detectable Antibodies” Journal of the American Academy of Dermatology, 2007, Jan; 56(1): 153-9
6 Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A, “Cutaneous Malignant Melanoma” Mayo Clinic Proceedings 2006 April 81(4): 500-7
7 Mamelak AJ, Kowalski J, Murphy K, Yadava N, Zahurak M, Kouba DJ, Howell BG, Tzu J, Cummins DL, Liegeois NJ, Berg K, Sauder DN. “Downregulation of NDUFA1 and other oxidative phosphorylation-related genes is a consistent feature of basal cell carcinoma” Exp Dermatol. 2005 May; 14(5) : 336-48